M. Platé (London, United Kingdom), A. Mailleux (Paris, France), O. Burgy (Aurora, United States of America), M. Konigshoff (Denver, United States of America)
LSC - 2018 - Distinct metabolic alterations in airway macrophages during pulmonary fibrosis
P. Ogger, T. Maher (t.maher@rbht.nhs.uk / Royal Brompton Hospital,London), C. Lloyd (c.lloyd@imperial.ac.uk / Imperial College London,London), A. Byrne (a.byrne@imperial.ac.uk / Imperial College London,London)
|  |
LSC - 2018 - MTOR regulates TGFß-induced collagen synthesis via increased glycine biosynthesis
I. Azuelos, B. Selvarajah (brintha.hayes@ucl.ac.uk / UCL,London), M. Plate (m.plate@ucl.ac.uk / UCL,London), H. Woodcock (h.woodcock@ucl.ac.uk / UCL,London), A. Taylor (adam.2.taylor@gsk.com / GSK,London), G. Brunori (Gino.2.Brunori@gsk.com / GSK,Ware), A. Blanchard (andy.d.blanchard@gsk.com / GSK,Stevenage), P. Mercer (paul.mercer@ucl.ac.uk / UCL,London), R. Chambers (r.chambers@ucl.ac.uk / UCL,London)
| |
LSC - 2018 - Material properties of lung scaffolds derived from healthy and IPF donor tissues are associated with disease pathology
L. Elowsson, A. Lofdahl (anna.lofdahl@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund), O. Rosmark (oskar.rosmark@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund), C. Muller (catharina.muller@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund), A. Larsson Callerfelt (anna-karin.larsson_callerfelt@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund), J. Malmstrom (johan.malmstrom@med.lu.se / Division of Infection Medicine, C. Sciences, L. University,Lund), E. Ahrman (emma.ahrman@med.lu.se / Division of Infection Medicine, C. Sciences, L. University,Lund), G. Westergren-Thorsson (gunilla.westergren-thorsson@med.lu.se / Lung Biology, E. Medical Science, L. University,Lund)
| |
Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling.
J. Katzen (Philadelphia, United States of America), A. Venosa (Philadelphia, United States of America), Y. Tomer (Philadelphia, United States of America), M. Morley (Philadelphia, United States of America), S. Nureki (Oita, Japan), M. Beers (Philadelphia, United States of America)
| |
The hypoxia-inducible factor 1a protein stabilizers inhibit transforming growth factor ß-induced extracellular matrix proteins in epithelial cells and fibroblasts.
A. Ando (Nagoya, Japan), N. Hashimoto (Nagoya, Japan), K. Sakamoto (Nagoya, Japan), Y. Hasegawa (Nagoya, Japan)
| |
Effective LncRNAs on myofibroblast differentiation in human A549 cell line treated with TGF-ß
M. Yildirim (Istanbul, Turkey), O. Kayalar (Istanbul, Turkey), F. Oztay (Istanbul, Turkey)
| |
Anti-fibrotic effect of Atorvastatin on the lung fibroblasts and myofibroblasts
M. Yildirim (Istanbul, Turkey), O. Kayalar (Istanbul, Turkey), E. Atahan (Istanbul, Turkey), F. Oztay (Istanbul, Turkey)
| |
Effect of NAPDH oxidase inhibitors on lung fibroblast proliferation in systemic sclerosis
T. Hua-Huy (Paris, France), C. Nicco (Paris, France), J. Boucher (Paris, France), H. Vu-Ngoc (Paris, France), E. Tran-Van-Hoi (Paris, France), F. Batteux (Paris, France), A. Slama-Schwok (Jouy en Josas, France), A. Dinh-Xuan (Paris, France)
|  |
Development of improved method to identify and analyze lung fibrocytes with flow cytometry in a reporter mouse strain
H. Kawano (Tokushima , Japan), K. Koyama (Tokushima , Japan), H. Nishimura (Tokushima , Japan), Y. Toyoda (Tokushima , Japan), K. Kagawa (Tokushima , Japan), S. Sato (Tokushima , Japan), N. Naito (Tokushima , Japan), H. Goto (Tokushima , Japan), Y. Inagaki (Isehara, Japan), Y. Nishioka (Tokushima , Japan)
| |
Unravelling specific mechanisms of wound healing and pulmonary fibrosis in human ex vivo lung tissue slices
C. Hesse (Hannover, Germany), S. Mang (Biberach an der Riss, Germany), S. Wollin (Biberach an der Riss, Germany), M. Niehof (Hannover, Germany), P. Braubach (Hannover, Germany), D. Jonigk (Hannover, Germany), M. Kühnel (Hannover, Germany), G. Warnecke (Hannover, Germany), O. Pfennig (Hannover, Germany), H. Fieguth (Hannover, Germany), A. Braun (Hannover, Germany), K. Sewald (Hannover, Germany)
| |
Mast cells and tryptase have migratory effect on human lung fibroblasts that is PAR-2 dependent
M. Bagher (Lund, Sweden), A. Larsson-Callerfelt (Lund, Sweden), O. Hallgren (Lund, Sweden), L. Bjermer (Lund, Sweden), G. Westergren-Thorsson (Lund, Sweden)
| |
Erythropoietin (EPO) attenuates the immunohistochemical expression of tumor growth factor-ß (TGF-ß) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
D. Tsavlis (THESSALONIKI, Greece), D. Anestakis (THESSALONIKI, Greece), A. Tzoumaka (THESSALONIKI, Greece), C. Symeonidou (THESSALONIKI, Greece), K. Kouzi - Koliakou (THESSALONIKI, Greece), A. Tektonidou (THESSALONIKI, Greece), E. Spandou (THESSALONIKI, Greece)
| |
Eosinophilic inflammation and worsening of lung function upon pirfenidone treatment in Fra-2 transgenic mice
A. Gungl (Graz, Austria), V. Biasin (Graz, Austria), C. Slaven (Graz, Austria), L. Marsh (Graz, Austria), G. Kwapiszewska (Graz, Austria), H. Olschewski (Graz, Austria)
| |
A novel chronic murine model of idiopathic pulmonary fibrosis
K. Simon (Brasília, Brazil), C. Melo-Silva (Brasília, Brazil), P. Veloso-Junior (Brasília, Brazil), V. Amado (Brasília, Brazil), F. Figueiredo (Brasília, Brazil), A. Bocca (Brasília, Brazil)
|  |
Analysis of the lung microbiota in healthy dogs and in canine idiopathic pulmonary fibrosis, a possible spontaneous model for human IPF.
A. Fastrès (Liège, Belgium), E. Roels (Liège, Belgium), B. Taminiau (Liège, Belgium), M. Rajamäki (Helsinky, Finland), G. Daube (Liège, Belgium), J. Guiot (Liège, Belgium), C. Clercx (Liège, Belgium)
| |
Protective roles of mannose receptor in an experimental pulmonary fibrosis model
M. Yamashita (Morioka, Japan), M. Niisato (Morioka, Japan), Y. Kawasaki (Morioka, Japan), M. Maemondo (Morioka, Japan)
| |
Time-course analysis of bleomycin-induced lung fibrosis in the rat
V. Pitozzi (Parma, Italy), P. Caruso (Parma, Italy), M. Bonatti (Parma, Italy), F. Bignami (Parma, Italy), M. Pittelli (Parma, Italy), S. Pontis (Parma, Italy), C. Frati (Parma, Italy), C. Mangiaracina (Parma, Italy), F. Quaini (Parma, Italy), C. Lagrasta (Parma, Italy), M. Civelli (Parma, Italy), G. Villetti (Parma, Italy), M. Trevisani (Parma, Italy)
| |
Role of regulatory T-cells (Tregs) in bacterial infection-induced lung fibrosis exacerbation in mice
S. Moyé (Hannover, Germany), R. Maus (Hannover, Germany), T. Sparwasser (Hannover, Germany), J. Gauldie (Hamilton, Canada), M. Kolb (Hamilton, Canada), T. Welte (Hannover, Germany), U. Maus (Hannover, Germany)
| |
The possible role of gastrin-releasing peptide on pulmonary fibrosis
Ö. Kayalar (Istanbul, Turkey), H. Öngen (Istanbul, Turkey), F. Oztay (Istanbul, Turkey)
| |